Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: rug Clear Filter

This Simple Strategy Could Curb One of Semaglutide’s Worst Side Effects

Semaglutide’s ability to help people lose weight is legendary, but so are the side effects. The active ingredient in medications Wegovy and Ozempic, semaglutide is renowned for causing severe nausea in some people, sometimes to the extent that they stop treatment. But new research published in the journal Diabetes Care suggests there may be a simple way to combat that effect. Led by a team in Israel, the researchers found that giving people more time and flexibility to ramp up to the recommende

Doctors Are Warning That Ozempic’s Severe Side Effects May Outweigh Its Benefits

Image by Roberto Pfeil / picture alliance via Getty / Futurism Rx/Medicines As weight loss jabs like Ozempic and Wegovy become ever more popular, doctors are growing increasingly concerned about their gnarly side effects. As Germany's Deutsche Welle notes, people who take glucagon-like peptide-1 (GLP-1) agonist/receptors, the class of drugs that the popular shots fall under, have reported everything from stomach issues and vision changes to erectile dysfunction and even suicide. Though clinic

First malaria treatment for babies approved for use

First malaria treatment for babies approved for use 4 days ago Share Save Dominic Hughes Global Health Correspondent Share Save Getty Images Malaria drugs for children do exist, but there are no treatments specifically for babies The first malaria treatment suitable for babies and very young children has been approved for use. It's expected to be rolled out in African countries within weeks. Until now there have been no approved malaria drugs specifically for babies. Instead they have been tr

New Study Flips Everything We Know About Addiction Upside Down

Since the 1970s, countless experts and the US government have sold the public a simple explanation for drug addiction, now clinically called substance abuse disorder: the myth of the gateway drug. The gateway drug — usually cast as weed, alcohol, tobacco, or inhalants — refers to the theory that the earlier a kid starts using drugs, the more likely they are to get into the harder stuff later in life, like heroin or cocaine. Though the idea was pioneered as early as the 1930s, the policy term wa

Diligent Robotics hires two notable Cruise alumni to its leadership team

Diligent Robotics is bulking up its leadership team as the company looks to scale its fleet of humanoid robots that work in hospitals and pharmacies. Austin, Texas-based Diligent announced Thursday it appointed Rashed Haq as its chief technology officer and Todd Brugger as its chief operating officer. Both Haq and Brugger were most recently at Cruise, the GM self-driving subsidiary that shuttered earlier this year. Haq was formerly the vice president and head of AI and robotics. Brugger was Cr

These Genetically Modified Mice Make Their Own ‘Ozempic’

The popularity of Ozempic and Wegovy as diabetes and weight loss medications has skyrocketed. But how far would people go to avoid one of their major drawbacks—the need for weekly injections? A study out today shows it’s possible to genetically modify mice to make their own Ozempic-like drugs. Scientists in Japan led the research, which involved gene-editing mice’s livers to produce an internal supply of exenatide, a first-generation GLP-1 drug. The edited mice were able to sustain levels of th

An AI That Promises to “Solve All Diseases” Is About to Test Its First Human Drugs

Deep inside Alphabet, the parent company of Google, a secretive lab is working on a promise so audacious it sounds like science fiction: to “solve all diseases.” The company, Isomorphic Labs, is now preparing to start its first human clinical trials for cancer drugs designed entirely by artificial intelligence. In a recent interview with Fortune, Colin Murdoch, President of Isomorphic Labs and Chief Business Officer of Google DeepMind, confirmed the company is on the verge of this monumental st

Overcoming Technical Barriers in Desktop and Application Virtualization

As organizations increasingly embrace remote and hybrid work, desktop and application virtualization have become essential strategies for ensuring flexibility, scalability, and security. However, implementing these solutions presents several technical challenges that IT leaders must address to maintain seamless operations and robust security. This article explores these challenges and highlights proven strategies for overcoming them. Securing Virtual Environments in the Face of Evolving Threa

Colombia seizes first unmanned narco-submarine with Starlink antenna

Photograph released by the Colombian Navy press office showing an unmanned semi-submersible, known as a Low Profile Vessel, between two Colombian Navy vessels, July 2, 2025. The Colombian navy on Wednesday announced its first seizure of an unmanned narco-submarine equipped with a Starlink antenna off its Caribbean coast. The vessel was not carrying drugs, but the Colombian navy and Western security sources based in the region told AFP they believed it was a trial run of an unmanned vessel by a

RFK Jr.’s plan to put ‘AI’ in everything is a disaster

In a 92-minute interview with Tucker Carlson on Monday, RFK Jr. drilled down on his vision for the US Department of Health and Human Services (HHS). Artificial intelligence — arguably, a uselessly vague umbrella term — came up multiple times. (As did conspiracy theories and disinformation on vaccines and autism, the medical establishment, and covid-19 deaths.) As the head of HHS, Kennedy said his federal department is undergoing an “AI revolution.” He implored viewers to “stop trusting the expe

Could Ozempic Treat Migraines, Too? Small Study Finds Early Promise for GLP-1s

Got a blinding headache? Some GLP-1 therapy could surprisingly help. A recent clinical trial has found early evidence that these popular drugs, typically used to treat obesity and type 2 diabetes, may also reduce migraine episodes. Researchers in Italy conducted the small pilot trial, which involved dozens of patients living with obesity and chronic migraine headaches. People experienced a significant drop in the number of migraine days each month upon taking liraglutide, the researchers found—

The best rugged phones in 2025 (including Samsung and Oukitel)

The best mainstream smartphones like the Apple iPhone, Samsung Galaxy and Google Pixel phones offer sharp displays, powerful performance, and versatile cameras. They are IP-rated for dust and water resistance, but most of them won't be enough if you're an adventurer. If you like hiking or camping, you should consider buying one of the top rugged phones. They are meant to withstand rough elements. The top contenders on this list are tested for military-standard durability, so you don't have to w

The Download: how to clean up AI data centers, and weight-loss drugs’ side effects

In a sandy industrial lot outside Reno, Nevada, rows of battery packs that once propelled electric vehicles are now powering a small AI data center. Redwood Materials, one of the US’s largest battery recycling companies, showed off this array of energy storage modules, sitting on cinder blocks and wrapped in waterproof plastic, during a press tour at its headquarters on June 26. The event marked the launch of the company's new business line, Redwood Energy, which will initially repurpose (

The Next Acetaminophen Tablet You Take Could Be Made From PET

Researchers at the University of Edinburgh have succeeded in transforming certain plastic waste into acetaminophen using the natural properties of the common bacterium Escherichia coli (E. coli). This breakthrough represents a milestone with the potential to drive more sustainable methods of drug production and, at the same time, contribute to the reduction of plastic pollution globally. The study, led by Stephen Wallace, revealed that E. coli cells contain phosphate, an organic compound capabl

Spike in Pancreas Problems From Weight-Loss Drugs Prompts Investigation

Ozempic and similar GLP-1 drugs seem to be hurting some people’s pancreas. UK health officials are planning to study the link between GLP-1 use and acute pancreatitis, following an increase in reported cases this year. The Guardian reported Tuesday that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is launching an investigation into pancreatitis associated with the drug class. Hundreds of residents have complained about pancreas problems after taking semaglutide or other r

OpenAI vs. iyO: Key takeaways from the new legal filings

Yesterday evening, TechCrunch reported on a series of new legal filings made by OpenAI in the iyO trademark lawsuit that led to the scrubbing of the ‘io’ brand on OpenAI’s website. The documents, filed by OpenAI’s CEO Sam Altman as well as ex-Apple employees Evans Hankey, Tang Tan, and Marwan Rammah (now all at io Products), reveal as much about the company’s ambitions as they do about what it hopes to keep under wraps. Here are a few key takeaways. 1: iyO tried to hire Evans Hankey In 2022,

Sam Altman takes his ‘io’ trademark battle public

is a news writer who covers the streaming wars, consumer tech, crypto, social media, and much more. Previously, she was a writer and editor at MUO. OpenAI CEO Sam Altman has put a spotlight on private conversations leading up to a rival company suing OpenAI over its upcoming device, io. On Tuesday, Altman posted screenshots of emails on X showing messages between him and Jason Rugolo, the founder of the Iyo hearing device startup that’s suing OpenAI. The emails show a mostly friendly exchange w

OpenAI vs. ioY: Key takeaways from the new legal filings

Yesterday evening, TechCrunch reported on a series of new legal filings made by OpenAI in the ioY trademark lawsuit that led to the scrubbing of the ‘io’ brand on OpenAI’s website. The documents, filed by OpenAI’s CEO Sam Altman as well as ex-Apple employees Evans Hankey, Tang Tan, and Marwan Rammah (now all at io Products), reveal as much about the company’s ambitions as they do about what it hopes to keep under wraps. Here are a few key takeaways. 1: iyO tried to hire Evans Hankey In 2022,

Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs

Bad blood is brewing among some major players in the weight loss world. Novo Nordisk, the creator of Ozempic and Wegovy, cut short its partnership with telehealth company Hims & Hers Health Inc. over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs. Bloomberg News reported the abrupt dissolution of the partnership Monday, just two months after it was struck. Novo claims that Hims is using “deceptive marketing” to widely sell compounded semaglutide t

Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s

Eli Lilly’s daily anti-obesity pill orforglipron appears to be as good at spurring weight loss and lowering blood sugar in diabetes patients as popular injectable GLP-1 drugs like Ozempic, according to new data from a Phase 3 trial. The results were announced today at the annual meeting of the American Diabetes Association and published in the New England Journal of Medicine. Eli Lilly is the maker of the blockbuster GLP-1 drug tirzepatide, approved as Mounjaro for type 2 diabetes and Zepbound

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

The US Food and Drug Administration has just approved lenacapavir, an injectable form of HIV prevention that is almost 100 percent effective and requires only two doses per year. Science magazine described the medicine the most important scientific advance of 2024. In clinical trials, lenacapavir proved to be 99.9 percent effective in preventing HIV infection through sexual transmission in people weighing more than 35 kilograms. The drug, an antiretroviral, works not by stimulating an immune re

FDA Approves ‘Breakthough’ Drug to Prevent HIV

The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient form of pre-exposure prophylaxis (PrEP). In clinical trials, the drug was shown to be highly effective at preventing HIV infection when taken just twice a year. At the same time, advocates are urging Gilead and U.S. officials to ensure the drug is widely accessible to the public. “PrEP is one of

The Grug Brained Developer (2022)

The Grug Brained Developer A layman's guide to thinking like the self-aware smol brained Introduction this collection of thoughts on software development gathered by grug brain developer grug brain developer not so smart, but grug brain developer program many long year and learn some things although mostly still confused grug brain developer try collect learns into small, easily digestible and funny page, not only for you, the young grug, but also for him because as grug brain developer get

Topics: big brain code good grug

Surgery Still Beats Ozempic and Other GLP-1 Drugs in Real-World Weight Loss Study

When it comes to weight loss, surgery still reigns supreme. Research out today shows that people undergoing bariatric surgery tend to lose significantly more weight than people taking the newest, most effective GLP-1 medications for obesity. Scientists at New York University conducted the study, which analyzed real-world data from obesity patients. People who received surgery lost five times more weight over a two year span on average than those who were prescribed a GLP-1 drug, they found. The

Threat in Your Medicine Cabinet: The FDA's Gamble on America's Drugs

The Food and Drug Administration’s 2022 inspection of the Sun Pharma factory in India warned of contaminations and deficiencies. But the plant received permission from the FDA to continue shipping more than a dozen generic medications to Americans. We are still reporting. If you are a current or former FDA employee or someone in the industry with information about the agency, the safety of generic drugs, or the manufacturers that make them, our team wants to hear from you. Megan Rose can be rea

A New Obesity Pill May Burn Fat Without Suppressing Appetite

An experimental obesity pill that works in a different way from the wildly popular Ozempic may help people lose weight, according to results from a small, preliminary human trial. Ozempic and other GLP-1 drugs reduce food intake by stimulating a feeling of fullness. They act on the brain to promote satiety and on the gut to slow the movement of food through the stomach, helping people feel full longer. As a result, people on the drugs lose weight because they eat less. But a new drug may be ab

We found a germ that 'feeds' on hospital plastic – new study

Plastic pollution is one of the defining environmental challenges of our time – and some of nature’s tiniest organisms may offer a surprising way out. In recent years, microbiologists have discovered bacteria capable of breaking down various types of plastic, hinting at a more sustainable path forward. These “plastic-eating” microbes could one day help shrink the mountains of waste clogging landfills and oceans. But they are not always a perfect fix. In the wrong environment, they could cause

The Download: gambling with humanity’s future, and the FDA under Trump

—Bryan Gardiner This story is from the next print edition of MIT Technology Review, which explores power—who has it, and who wants it. It’s set to go live on Wednesday June 25, so subscribe & save 25% to read it and get a copy of the issue when it lands! Here’s what food and drug regulation might look like under the Trump administration Earlier this week, two new leaders of the US Food and Drug Administration published a list of priorities for the agency. Both Marty Makary and Vinay Prasad

Topics: 25 drug food like look

Here’s what food and drug regulation might look like under the Trump administration

First, a bit of background. Makary, the current FDA commissioner, is a surgeon and was a professor of health policy at the Johns Hopkins School of Public Health. He initially voiced support for stay-at-home orders during the pandemic but later changed his mind. In February 2021, he incorrectly predicted that the US would “have herd immunity by April.” He has also been very critical of the FDA, writing in 2021 that its then leadership acted like “a crusty librarian” and that drug approvals were “

The FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI Chatbot

Image by Getty / Futurism In case you haven't had enough about artificial intelligence, the US Food and Drug Administration is now outsourcing its oversight duties to a large language model (LLM.) In an article published in the Journal of the American Medical Association (JAMA), FDA bureaucrats Marty Makary and Vinay Prasad — the latter of whom is a noted critic of COVID mask mandates and vaccine boosters — laid out a five-point list of priorities that the federal agency is hoping to tackle. A

Topics: ai drug elsa fda industry